- Home
- PRLD vs FNWB Comparison
PRLD vs FNWB Comparison
Compare PRLD & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- FNWB
- Stock Information
- Founded
- PRLD 2016
- FNWB 1923
- Country
- PRLD United States
- FNWB United States
- Employees
- PRLD N/A
- FNWB N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- FNWB Banks
- Sector
- PRLD Health Care
- FNWB Finance
- Exchange
- PRLD Nasdaq
- FNWB Nasdaq
- Market Cap
- PRLD 69.1M
- FNWB 69.0M
- IPO Year
- PRLD 2020
- FNWB 2015
- Fundamental
- Price
- PRLD $1.42
- FNWB N/A
- Analyst Decision
- PRLD Strong Buy
- FNWB Hold
- Analyst Count
- PRLD 3
- FNWB 1
- Target Price
- PRLD $4.00
- FNWB $12.00
- AVG Volume (30 Days)
- PRLD 290.5K
- FNWB 25.5K
- Earning Date
- PRLD 11-05-2025
- FNWB 10-28-2025
- Dividend Yield
- PRLD N/A
- FNWB 3.52%
- EPS Growth
- PRLD N/A
- FNWB N/A
- EPS
- PRLD N/A
- FNWB N/A
- Revenue
- PRLD $7,000,000.00
- FNWB $48,874,000.00
- Revenue This Year
- PRLD N/A
- FNWB $34.16
- Revenue Next Year
- PRLD N/A
- FNWB $11.73
- P/E Ratio
- PRLD N/A
- FNWB N/A
- Revenue Growth
- PRLD N/A
- FNWB N/A
- 52 Week Low
- PRLD $0.61
- FNWB $6.05
- 52 Week High
- PRLD $2.08
- FNWB $12.10
- Technical
- Relative Strength Index (RSI)
- PRLD 60.29
- FNWB 57.54
- Support Level
- PRLD $1.33
- FNWB $7.65
- Resistance Level
- PRLD $1.63
- FNWB $7.99
- Average True Range (ATR)
- PRLD 0.18
- FNWB 0.22
- MACD
- PRLD 0.01
- FNWB 0.06
- Stochastic Oscillator
- PRLD 49.42
- FNWB 52.14
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.